FDA
-
-
-
-
-
-
-
Acurx Pharmaceuticals, Inc. To Present at The Market Movers Investor Summit
-
-
-
-
-
-
-
New to The Street Resigns Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) to Continue Long-Form Interview Series, Outdoor Media Campaigns and Accredited Investor Events
-
-
-
-
-
-
-
Acurx Pharmaceuticals, Inc. Reports Third Quarter Results and Provides Business Update
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Acurx Pharmaceuticals inc. (ACXP)
-
-
-
-
-
-
-
Acurx Pharmaceuticals, Inc. Announces Reverse Stock Split
-
-
-
-
-
-
-
Acurx Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 13, 2025 Conference Call and Provide Business Update
-
-
-
-
-
-
-
Acurx Pharmaceuticals, Inc. Announces $1.1 Million Registered Direct Offering
-
323,573 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

